Our Evidence – mPATH

mPATH^® Doubles Colorectal Cancer Screening Rates

In a large randomized controlled trial funded by the National Cancer Institute, mPATH doubled the number of patients who completed screening for colorectal cancer. Patients in this study faced significant barriers to care: one-third had limited literacy and half had annual incomes below $20,000. Despite these barriers, mPATH was able to double cancer screening and found over twice as many patients with pre-cancerous polyps.

Reference: Miller DP et al. Effect of a Digital Health Intervention on Receipt of Colorectal Cancer Screening in Vulnerable Patients. Annals of Internal Medicine 2018.

mPATH™ Doubles Colorectal Cancer Screening Rates

In a large randomized controlled trial funded by the National Cancer Institute, mPATH™ doubled the number of patients who completed screening for colorectal cancer. Patients in this study faced significant barriers to care: one-third had limited literacy and half had annual incomes below $20,000. Despite these barriers, mPATH™ was able to double cancer screening and found over twice as many patients with pre-cancerous polyps.

Reference: Miller DP et al. Effect of a Digital Health Intervention on Receipt of Colorectal Cancer Screening in Vulnerable Patients. Annals of Internal Medicine 2018.

40% of Invited Patients Visit mPATH. Almost Everyone Completes It

We sent a patient portal (MyChart) outreach message to 1000 randomly selected patients who may be overdue for lung cancer screening. Over 400 patients visited mPATH in response, and 86% of all visitors completed the program.

Reference: Dharod A et al. The Reach and Feasibility of an Interactive Lung Cancer Screening Decision Aid Delivered by Patient Portal. Applied Clinical Informatics 2019

Electronic Health Record Data Misses Two-Thirds Of Patients Who Need Lung Cancer Screening. mPATH Finds Them All.

Whether or not a patient needs lung cancer screening depends on their age, how much they have smoked, and when (if ever) they quit smoking. In one of our pilot studies, mPATH found over 330 patients who needed lung cancer screening. Of these patients, the Electronic Health Record only identified 35% of them as needing screening. Relying on the Electronic Health Record alone would miss two-thirds of people who could benefit from this life saving test.

Reference: Patel N et al. A Comparison of Smoking History in the Electronic Health Record with Self-Report. American Journal of Preventive Medicine 2020.

Electronic Health Record Data Misses Two-Thirds Of Patients Who Need Lung Cancer Screening. mPATH™ Finds Them All.

Whether or not a patient needs lung cancer screening depends on their age, how much they have smoked, and when (if ever) they quit smoking. In one of our pilot studies, mPATH™ found over 330 patients who needed lung cancer screening. Of these patients, the Electronic Health Record only identified 35% of them as needing screening. Relying on the Electronic Health Record alone would miss two-thirds of people who could benefit from this life saving test.

Reference: Patel N et al. A Comparison of Smoking History in the Electronic Health Record with Self-Report. American Journal of Preventive Medicine 2020.

mPATH Detects Over Twice As Many Patients With Depression, Fall Risk, Or Intimate Partner Violence.

In a study involving 23,000 patients in six different primary care clinics, mPATH identified over twice as many patients with concerns that could warrant immediate clinical action. Compared to usual screening by nursing staff, mPATH identified over twice as many patients with depression (4% vs. 1.5%), fall risk (16% vs 6%), or intimate partner violence (3% vs 0.1%). We are proud that mPATH finds those who may need help.

Reference: Miller DP et al. Universal Screening in Primary Care Practices by Self-administered Tablet vs Nursing Staff. JAMA Network Open 2022.